Fair comment, market cap for RAP is 3 times that of AHZ, BIT 1 plus, put cash outflows for the two aside, what does the two have in comparison to Admedus, in regards to revenue stream and the IP Admedus has? Vacc ‘alive’ at phase two plus (?), though in administration, recognition of Adapt IP and hype of TAVR R&D?
Just saying, trying to find a positive, previous history and baggage of Admedus is certainly ‘dagging’ this stock, imo.
Discrepancy is where?
@ChillyDog; what are the facts mate??, can you substantiate?, where is the announcement?
Under the Radar, page-518
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |